Pieris Pharmaceuticals, Inc. (PIRS): Price and Financial Metrics
PIRS Price/Volume Stats
| Current price | $17.04 | 52-week high | $27.96 |
| Prev. close | $17.25 | 52-week low | $6.20 |
| Day low | $17.00 | Volume | 1,700 |
| Day high | $17.30 | Avg. volume | 56,531 |
| 50-day MA | $13.71 | Dividend yield | N/A |
| 200-day MA | $13.20 | Market Cap | 22.49M |
PIRS Stock Price Chart Interactive Chart >
Pieris Pharmaceuticals, Inc. (PIRS) Company Bio
Pieris Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, discovers and develops Anticalin-based drugs. The company develops Anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in blood plasma and other bodily fluids. The company is based in Boston, Massachusetts.
Latest PIRS News From Around the Web
Below are the latest news stories about PIERIS PHARMACEUTICALS INC that investors may wish to consider to help them evaluate PIRS as an investment opportunity.
Will Pieris Pharmaceuticals (NASDAQ:PIRS) Spend Its Cash Wisely?Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayPre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning! |
Pieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's WhyPieris Pharmaceuticals (PIRS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to close out this week of trading with an overview of the biggest pre-market stock movers to watch Friday morning! |
Is Pieris Pharmaceuticals (PIRS) a Value Trap? A Comprehensive AnalysisUnpacking the Risks and Rewards of Investing in Pieris Pharmaceuticals |
PIRS Price Returns
| 1-mo | 9.79% |
| 3-mo | 66.24% |
| 6-mo | 25.29% |
| 1-year | -29.00% |
| 3-year | -95.93% |
| 5-year | -95.54% |
| YTD | 17.03% |
| 2023 | -82.50% |
| 2022 | -72.49% |
| 2021 | 51.20% |
| 2020 | -30.94% |
| 2019 | 36.09% |
Continue Researching PIRS
Want to see what other sources are saying about Pieris Pharmaceuticals Inc's financials and stock price? Try the links below:Pieris Pharmaceuticals Inc (PIRS) Stock Price | Nasdaq
Pieris Pharmaceuticals Inc (PIRS) Stock Quote, History and News - Yahoo Finance
Pieris Pharmaceuticals Inc (PIRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...